EX-99 2 exh.txt 77C Matters submitted to a vote of security holders Columbia International Stock Fund On September 16, 2005, a Special Meeting of the Shareholders of the Fund was held to approve the following items, as described in the combined Proxy Statement/Prospectus for the Meeting. However the meeting was adjourned to October 7, 2006 and the votes cast at the Meeting were as follows: To elect Trustees: For Withheld Abstain Douglas A. Hacker 60,692,513.017 220,690.932 159,889.416 Janet Langford Kelly 60,702,370.024 210,982.838 159,740.503 Richard W. Lowry 60,706,258.322 210,326.218 156,508.825 Charles R. Nelson 60,704,747.612 211,433.833 156,911.920 John J. Neuhauser 60,741,054.998 211,309.437 120,728.930 Patrick J. Simpson 60,704,428.675 208,775.274 159,889.416 Thomas E. Stitzel 60,695,887.027 217,316.922 159,889.416 Thomas C. Theobald 60,695,720.657 217,483.292 159,762.956 Anne-Lee Verville 60,704,612.622 208,717.787 159,762.956 Richard L. Woolworth 60,705,828.698 207,375.251 159,889.416 William E. Mayer 7,632,312.660 53,282,477.996 158,302.709 Amendment to fundamental investment restrictions with respect to borrowing money, pledging assets, and issuing senior securities. For: 57,715,403.773 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 276,529.024 Shares of beneficial interest Abstain: 304,384.568 Shares of beneficial interest Amendment to fundamental investment restrictions with respect to making loans For: 57,687,275.385 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 304,771.368 Shares of beneficial interest Abstain: 304,270.612 Shares of beneficial interest Amendment to fundamental investment restrictions with respect to diversification of investments. For: 57,759,093.688 shares of beneficial interest being a majority of the shares represented at the meeting. Against: 235,934.648 shares of beneficial interest Abstain: 301,289.029 shares of beneficial interest Amendment to fundamental investment restrictions with respect to investments in commodities For: 57,716,198.942 shares of beneficial interest being a majority of the shares represented at the meeting. Against: 293,577.052 shares of beneficial interest Abstain: 286,541.371 shares of beneficial interest Amendment to fundamental investment restrictions with respect to investments in real estate. For: 57, 766,604.228 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 232,581.748 Shares of beneficial interest Abstain: 297,131.389 Shares of beneficial interest Amendment to fundamental investment restrictions with respect to underwriting of securities. For: 57,694,982.153 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 296,566.166 Shares of beneficial interest Abstain: 304,769.046 Shares of beneficial interest Elimination of fundamental inv restrictions with respect to investing for the purpose of exercising control. For: 57,712,869.829 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 276,880.811 Shares of beneficial interest Abstain: 306,566.725 Shares of beneficial interest Elimination of fundamental investment restrictions with respect to short sales. For: 57,658,972.134 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 341,402.400 Shares of beneficial interest Abstain: 295,942.831 Shares of beneficial interest Amendment of fundamental investment restrictions with respect to concentrating investments in an industry. For: 57,709,496.421 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 290,360.008 Shares of beneficial interest Abstain: 296,460.936 Shares of beneficial interest Elimination of fundamental investment restrictions with respect to purchasing securities of companies less than three years old. For: 57,714,444.740 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 289,082.653 Shares of beneficial interest Abstain: 292,789.972 Shares of beneficial interest Elimination of fundamental investment restrictions with respect to buying and selling puts and calls. For: 57, 655,905.693 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 342,459.762 Shares of beneficial interest Abstain: 297,951.910 Shares of beneficial interest To approve the Reorganization of each Fund into a separate, corresponding series of Columbia Funds Trust. For: 57, 738,183.266 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 236,336.008 Shares of beneficial interest Abstain: 321,798.091 Shares of beneficial interest Columbia Federal Securities Fund On September 16, 2005, a Special Meeting of the Shareholders of the Funds was held to approve the following items, as described in the Proxy Statement for the Meeting. The votes cast at the Meeting were as follows: To elect Trustees: For Withheld Douglas A. Hacker 251,538,910.788 4,263,833.338 Janet Langford Kelly 251,528,357.353 4,274,386.773 Richard W. Lowry 251,683,555.163 4,119,188.963 Charles R. Nelson 251,750,297.178 4,052,446.948 John J. Neuhauser 251,738,893.036 4,063,851.090 Patrick J. Simpson 251,810,145.436 3,992,598.690 Thomas E. Sitzel 251,716,092.327 4,086,651.799 Thomas C. Theobald 251,754,592.177 4,048,151.949 Anne-Lee Verville 251,490,856.305 4,311,887.821 Richard L. Woolworth 251,630,779.504 4,171,964.622 William E. Mayer 147,422,123.221 108,380,620.905 Shares of beneficial interest being a plurality of the shares represented at the Meeting. 2a: Amend fundamental investment restrictions with respect to borrowing money, pledging assets, and issuing senior securities. For: 36,225,929.823 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 1,234,528.433 Shares of beneficial interest Abstain: 1,433,978.433 Shares of beneficial interest 2b: Amendment to fundamental investment restrictions with respect to making loans For: 36,358,975.179 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 1,213,059.225 Shares of beneficial interest Abstain: 1,322,402.601 Shares of beneficial interest 2c: Amendment to fundamental investment restrictions with respect to diversification of investments. For: 36,647,575.711 shares of beneficial interest being a majority of the shares represented at the meeting. Against: 915,354.580 shares of beneficial interest Abstain: 1,331,506.714 shares of beneficial interest 2e: Amendment to fundamental investment restrictions with respect to investments in real estate. For: 36,403,434.578 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 1,112,263.496 Shares of beneficial interest Abstain: 1,378,738.931 Shares of beneficial interest 2f: Amendment to fundamental investment restrictions with respect to underwriting of securities. For: 36,253,854.232 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 1,213,767.516 Shares of beneficial interest Abstain: 1,426,815.257 Shares of beneficial interest 2g: Elimination of fundamental investment restrictions with respect to purchasing securities on margin. For: 35,834,864.501 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 1,670,426.863 Shares of beneficial interest Abstain: 1,389,145.641 Shares of beneficial interest 2j: Amendment of fundamental investment restrictions with respect to concentrating investments in an industry. For: 36,359,904.423 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 1,182,407.888 Shares of beneficial interest Abstain: 1,352,124.694 Shares of beneficial interest Columbia Balanced Fund 77C Matters submitted to a vote of security holders On September 16, 2005, a Special Meeting of the Shareholders of the Fund was held to approve the following items, as described in the combined Proxy Statement/Prospectus for the Meeting. Item 3 was adjounred to November 16, 2005 and the votes cast at the September 16, 2005 Meeting were as follows: To elect Trustees: For Withheld Abstain ------------------------ ------------------------------------------------------ Douglas A. Hacker 6,940, 201.235 308,577.210. 295,302.351 Janet Langford Kelly 6,964, 696.209 284,340.669 295,043.918 Richard W. Lowry 6,964,177.596 288,775.096 291,128.104 Charles R. Nelson 6,955,242.511 293,794.367 295,043.918 John J. Neuhauser 6,938,643.232 310,483.416 294,954.148 Patrick J. Simpson 6,960,657.588 288,379.290 295,043.918 Thomas E. Stitzel 6,944,041.325 305,056.304 294,983.167 Thomas C. Theobald 6,957,230.830 291,806.048 295,043.918 Anne-Lee Verville 6,963,861.877 285,518.371 294,700.548 Richard L. Woolworth 6,955,689.866 293,436.782 294,954.148 William E. Mayer 6,931,053.839 318,451.218 294,575.739 Amend fundamental investment restrictions with respect to borrowing money, pledging assets, and issuing senior securities. For: 5,677,118.125 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 438,709.201 Shares of beneficial interest Abstain: 755,071.470 Shares of beneficial interest Amendment to fundamental investment restrictions with respect to making loans For: 5,637,298.280 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 481,015.958 Shares of beneficial interest Abstain: 752,584.558 Shares of beneficial interest Amendment to fundamental investment restrictions with respect to diversification of investments. For: 5,767,710.298 shares of beneficial interest being a majority of the shares represented at the meeting. Against: 385,528.461 shares of beneficial interest Abstain: 717,660.037 shares of beneficial interest Amendment to fundamental investment restrictions with respect to investments in commodities For: 5,705,877.210 shares of beneficial interest being a majority of the shares represented at the meeting. Against: 463,310.919 shares of beneficial interest Abstain: 701,710.667 shares of beneficial interest Amendment to fundamental investment restrictions with respect to investments in real estate. For: 5,765,582.441 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 361,231.250 Shares of beneficial interest Abstain: 744,085.105 Shares of beneficial interest Amendment to fundamental investment restrictions with respect to underwriting of securities. For: 5,699,615.281 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 429,829.270 Shares of beneficial interest Abstain: 741,454.245 Shares of beneficial interest Elimination of fundamental investment restrictions with respect to investing for the purpose of exercising control. For: 5,684,790.726 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 441,224.308 Shares of beneficial interest Abstain: 744,883.762 Shares of beneficial interest Elimination of fundamental investment restrictions with respect to short sales. For: 5,656,821.470 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 462,108.914 Shares of beneficial interest Abstain: 751,968.412 Shares of beneficial interest Amendment of fundamental investment restrictions with respect to concentrating investments in an industry. For: 5,707,863.649 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 427,127.806 Shares of beneficial interest Abstain: 735,907.341 Shares of beneficial interest Elimination of fundamental investment restrictions with respect to purchasing securities of companies less than three years old. For: 5,732,613.809 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 414,072.005 Shares of beneficial interest Abstain: 724,212.982 Shares of beneficial interest Elimination of fundamental investment restrictions with respect to buying and selling puts and calls For: 5,654,036.786 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 455,143.922 Shares of beneficial interest Abstain: 761,718.088 Shares of beneficial interest 3. To approve the Reorganization of each Fund into a separate, corresponding series of Columbia Funds Trust. For: 5,707,485.621 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 368,227.911 Shares of beneficial interest Abstain: 795,185.264 Shares of beneficial interest 77C Matters submitted to a vote of security holers Columibia Balanced Fund cont'd On September 16, 2005, a Special Meeting of the Shareholders of the Fund was held to approve the following item, as described in the combined Proxy Statement/Prospectus for the Meeting. The following item was adjourned to November 16, 2005 and the the vote cast at the Meeting were as follows: 3. To approve the Reorganization of each Fund into a separate, corresponding series of Columbia Funds Trust. For: 8,047,453.492 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 513,964.799 Shares of beneficial interest Abstain: 1,116,885.801 Shares of beneficial interest 77C Matters submitted to a vote of security holders Columbia Greater China Fund On November 16, 2005, a Special Meeting of the Shareholders of the Funds was held to approve the following items, as described in the Proxy Statement for the Meeting. The votes cast at the Meeting were as follows: To elect Trustees: For Withheld Abstain Douglas A. Hacker 2,078, 110.987 130,673.899 3,524.075 Janet Langford Kelly 2,146,435.086 65,873.875 0.000 Richard W. Lowry 2,146,649.328 65,659.633 0.000 Charles R. Nelson 2,147,091.698 65,217.263 0.000 John J. Neuhauser 2,146,151.576 66,157.385 0.000 Patrick J. Simpson 2,146,724.153 65,584.808 0.000 Thomas E. Stitzel 2,145,527.091 66,781.870 0.000 Thomas C. Theobald 2,145,275.094 67,033.867 0.000 Anne-Lee Verville 2,147,806.001 64,502.960 0.000 Richard L. Woolworth 2,148,282.783 64,026.178 0.000 William E. Mayer 2,146,644.878 65,664.083 0.000 2a: Amendment to fundamental investment restrictions with respect to borrowing money. For: 1,528,520.030 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 130,231.098 Shares of beneficial interest Abstain: 49,811.833 Shares of beneficial interest 2b: Amendment to fundamental investment restrictions with respect to issuing senior securities. For: 1,512,969.729 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 139,443.583 Shares of beneficial interest Abstain: 56,149.649 Shares of beneficial interest 2c: Amendment to fundamental investment restriction with respect to making loans. For: 1,503,472.788 shares of beneficial interest being a majority of the shares represented at the meeting. Against: 144,474.233 shares of beneficial interest Abstain: 60,615.940 shares of beneficial interest 2d: Amendment to fundamental investment restrictions with respect to investment in real estate. For: 1,544, 135.519 shares of beneficial interest being a majority of the shares represented at the meeting. Against: 115,648.496 shares of beneficial interest Abstain: 48,778.946 shares of beneficial interest 2e: Amendment to fundamental investment restrictions with respect to underwriting of securities. For: 1,531,700.236 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 122,595.068 Shares of beneficial interest Abstain: 54,267.657 Shares of beneficial interest 2f: Amendment to fundamental investment restrictions with respect to concentrating investments in an industry. For: 1,528,318.378 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 126,131.708 Shares of beneficial interest Abstain: 54,112.875 Shares of beneficial interest 2g: Elimination of fundamental investment restriction for buying and selling future contracts and related options. For: 1,499,311.762 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 156,501.871 Shares of beneficial interest Abstain: 52,749.328 Shares of beneficial interest Columbia Conservative High Yield Fund (formerly Columbia High Yield Fund, Inc.) 77C Matters submitted to a vote of security holders On September 16, 2005, a Special Meeting of the Shareholders of the Fund was held to approve the following items, as described in the combined Proxy Statement/Prospectus for the Meeting. The meeting was adjourned to October 7, 2005. Below are the votes cast at the September 16, 2005 meeting: To elect Trustees: For Withheld Abstain Douglas A. Hacker 159,686,169.914 1,007,043.009 144,132.291 Janet Langford Kelly 159,780,718.885 912,494.038 144,132.291 Richard W. Lowry 159,754,439.891 938,773.032 144,132.291 Charles R. Nelson 159,795,305.752 897,907.171 144,132.291 John J. Neuhauser 159,767,619.752 925,593.171 144,132.291 Patrick J. Simpson 159,826,639.134 866,699.114 144,006.966 Thomas E. Stitzel 159,778,843.809 914,369.114 144,132.291 Thomas C. Theobald 159,702,388.897 990,824.026 144,132.291 Anne-Lee Verville 159,737,396.317 955,816.606 144,132.291 Richard L. Woolworth 159,809,757.123 883,455.800 144,132.291 William E. Mayer 90,732,479.015 69,960,859.233 144,006.966 Amendment to fundamental investment restrictions with respect to borrowing money, pledging assets, and issuing senior securities. For: 101, 912,218.092 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 4,544,703.162 Shares of beneficial interest Abstain: 1,626,551.953 Shares of beneficial interest Amendment to fundamental investment restrictions with respect to making loans For: 101,739,278.211 Shares of beneficial interest being a majority of the sharesrepresented at the meeting. Against: 4,618,040.892 Shares of beneficial interest Abstain: 1,726,154.111 Shares of beneficial interest Amendment to fundamental investment restrictions with respect to diversification of investments. For: 102,138,880.483 shares of beneficial interest being a majority of the shares represented at the meeting. Against: 4,213,794.171 shares of beneficial interest Abstain: 1,730,798.560 shares of beneficial interest Amendment to fundamental inv restrictions with respect to investments in commodities For: 101, 587,312.753 shares of beneficial interest being a majority of the shares represented at the meeting. Against: 4,698,234.050 shares of beneficial interest Abstain: 1,797,926.411 shares of beneficial interest Amendment to fundamental investment restrictions with respect to investments in real estate. For: 101, 927,240.580 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 4,401,069.188 Shares of beneficial interest Abstain: 1,755,163.446 Shares of beneficial interest Amendment to fundamental investment restrictions with respect to underwriting of securities. For: 101,833,699.462 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 4,400,527.377 Shares of beneficial interest Abstain: 1,849,246.375 Shares of beneficial interest Elimination of fundamental investment restrictions with respect to purchasing securities on margin. For: 100,996,727.226 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 5,237,406.157 Shares of beneficial interest Abstain: 1,849,339.831 Shares of beneficial interest Elimination of fundamental investment restrictions with respect to investing for the purpose of exercising control. For: 101,481,263.577 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 4,778,067.876 Shares of beneficial interest Abstain: 1,824,141.761 Shares of beneficial interest Elimination of fundamental investment restrictions with respect to short sales. For: 101,207,875.024 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 5,055,006.299 Shares of beneficial interest Abstain: 1,820,591.891 Shares of beneficial interest Amendment of fundamental investment restrictions with respect to concentrating investments in an industry. For: 101,766,979.460 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 4,540,296.611 Shares of beneficial interest Abstain: 1,776,197.143 Shares of beneficial interest Elimination of fundamental investment restrictions with respect to purchasing securities of companies less than three years old. For: 101,610,700.950 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 4,636,038.252 Shares of beneficial interest Abstain: 1,836,734.012 Shares of beneficial interest Fund investment restrictions for purchasing or holding securities of any company, if securities are owned by officers, directors, advisor. For: 101,632,204.827 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 4,617,179.115 Shares of beneficial interest Abstain: 1,834,089.272 Shares of beneficial interest On October 7, 2005, a Special Meeting of the Shareholders of the Fund was held to approve the following items, as described in the combined Proxy Statement/Prospectus for the Meeting. The votes cast at the Meeting were as follows: 3. To approve the Reorganization of each Fund into a separate, corresponding series of Columbia Funds Trust. For: 101,918,282.302 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 4,227,939.401 Shares of beneficial interest Abstain: 1, 937,251.511 Shares of beneficial interest Columbia Mid Cap Growth Fund COLUMBIA MID CAP GROWTH FUND (THE "FUND") 77C Matters submitted to a vote of security holders On September 16, 2005, a Special Meeting of the Shareholders of the Funds was held to approve the following items, as described in the combined Proxy Statement/Prospectus for the Meeting. The votes cast at the Meeting were as follows: To elect Trustees: For Withheld Abstain Douglas A. Hacker 22,032,629.013 950,061.187 466,804.492 Janet Langford Kelly 22,093,191.981 892,597.602 463,705.109 Richard W. Lowry 22,090,757.738 930,552.617 428,184.337 Charles R. Nelson 22,076,653.356 902,585.041 470,256.295 John J. Neuhauser 22,062,173.953 917,497.278 469,823.461 Patrick J. Simpson 22,079,153.365 899,858.181 470,483.146 Thomas E. Stitzel 22,069,114.790 911,209.229 469,170.673 Thomas C. Theobald 22,052,767.485 927,674.285 469,052.922 Anne-Lee Verville 22,064,556.795 914,766.331 470,171.566 Richard L. Woolworth 22,081,520.100 901,451.163 466,523.429 William E. Mayer 14,065,366.188 8,915,050.906 469,077.598 2a: Amendment to fundamental investment restrictions with respect to borrowing money, pledging assets, and issuing senior securities. For: 19,263,726.695 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 1,243,171.219 Shares of beneficial interest Abstain: 1,033,754.778 Shares of beneficial interest 2b: Amendment to fundamental investment restrictions with respect to making loans For: 19,148,718.584 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 1,340,982.510 Shares of beneficial interest Abstain: 1,050,951.598 Shares of beneficial interest 2c: Amendment to fundamental investment restrictions with respect to diversification of investments. For: 19,412,087.895 shares of beneficial interest being a majority of the shares represented at the meeting. Against: 1,098,179.223 shares of beneficial interest Abstain: 1,030,385.574 shares of beneficial interest 2d: Amendment to fundamental investment restrictions with respect to investments in commodities For: 19,209,572.236 shares of beneficial interest being a majority of the shares represented at the meeting. Against: 1,297,524.585 shares of beneficial interest Abstain: 1,033,555.871 shares of beneficial interest 2e: Amendment to fundamental investment restrictions with respect to investments in real estate. For: 19,380,537.375 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 1,142,926.021 Shares of beneficial interest Abstain: 1,017,189.296 Shares of beneficial interest 2f: Amendment to fundamental investment restrictions with respect to underwriting of securities. For: 19,200,630.359 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 1,274,151.176 Shares of beneficial interest Abstain: 1,057,871.157 Shares of beneficial interest 2h: Elimination of fundamental inv restrictions with respect to investing for the purpose of exercising control. For: 19,197,500.948 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 1,270,034.247 Shares of beneficial interest Abstain: 1,073,117.497 Shares of beneficial interest 2i: Elimination of fundamental investment restrictions with respect to short sales. For: 19,132,217.743 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 1,244,344.627 Shares of beneficial interest Abstain: 1,064,200.322 Shares of beneficial interest 2j: Amendment of fundamental investment restrictions with respect to concentrating investments in an industry. For: 19,246,079.812 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 1,251,613.899 Shares of beneficial interest Abstain: 1,042,958.981 Shares of beneficial interest 2k: Elimination of fundamental investment restrictions with respect to purchasing securities of companies less than three years old. For: 19,300,105.248 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 1,194,630.107 Shares of beneficial interest Abstain: 1,045,917.337 Shares of beneficial interest 2m: Elimination of fundamental investment restrictions with respect to buying and selling puts and calls. For: 19,128,233.406 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 1,348,857.763 Shares of beneficial interest Abstain: 1,063,561.523 Shares of beneficial interest 3. To approve the Reorganization of each Fund into a separate, corresponding series of Columbia Funds Trust. For: 19,316,945.826 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 1,117,124.291 Shares of beneficial interest Abstain: 1,106,582.575 Shares of beneficial interest Columbia Real Estate Equity Fund 77C Matters submitted to a vote of security holders On September 16, 2005, a Special Meeting of the Shareholders of the Fund was held to approve the following items, as described in the combined Proxy Statement/Prospectus for the Meeting. The meeting was adjourned to October 7, 2005. Below are the votes cast at the September 16, 2005 meeting: To elect Trustees: For Withheld Abstain Douglas A. Hacker 21,431,512.292 544,304.685 139,141.875 Janet Langford Kelly 21,457,029.746 518,787.231 139,141.875 Richard W. Lowry 21,447,570.010 530,599.850 136,788.992 Charles R. Nelson 21,497,176.092 514,436.898 103,345.862 John J. Neuhauser 21,457,914.392 517,902.585 139,141.875 Patrick J. Simpson 21,460,656.322 515,160.655 139,141.875 Thomas E. Stitzel 21,452,702.948 523,114.029 139,141.875 Thomas C. Theobald 21,445,519.045 530,329.852 139,109.955 Anne-Lee Verville 21,456,460.921 519,356.056 139,141.875 Richard L. Woolworth 21,463,951.527 514,548.011 136,459.314 William E. Mayer 21,074,716.312 901,100.665 139,141.875 2a: Amendment to fundamental investment restrictions with respect to borrowing money, pledging assets, and issuing senior securities. For: 14, 866,641.836 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 843,163.706 Shares of beneficial interest Abstain: 571,678.310 Shares of beneficial interest 2b: Amendment to fundamental investment restrictions with respect to making loans For: 14,856,750.293 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 847,624.201 Shares of beneficial interest Abstain: 577,109.358 Shares of beneficial interest 2c: Amendment to fundamental investment restrictions with respect to diversification of investments. For: 14,959,526.094 shares of beneficial interest being a majority of the shares represented at the meeting. Against: 740,674.521 shares of beneficial interest Abstain: 581,283.237 shares of beneficial interest 2d: Amendment to fundamental inv restrictions with respect to investments in commodities For: 14,859,947.022 shares of beneficial interest being a majority of the shares represented at the meeting. Against: 859,707.846 shares of beneficial interest Abstain: 561,828.984 shares of beneficial interest 2e: Amendment to fundamental investment restrictions with respect to investments in real estate. For: 15,055,133.414 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 635,119.324 Shares of beneficial interest Abstain: 591,231.114 Shares of beneficial interest 2f: Amendment to fundamental investment restrictions with respect to underwriting of securities. For: 14,877,308.016 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 798,083.593 Shares of beneficial interest Abstain: 606,092.243 Shares of beneficial interest 2g: Elimination of fundamental investment restrictions with respect to purchasing securities on margin For: 14,684,147.178 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 1,007,424.173 Shares of beneficial interest Abstain: 589,912.501 Shares of beneficial interest 2h: Elimination of fundamental inv restrictions with respect to investing for the purpose of exercising control. For: 14,838,094.859 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 846,589.816 Shares of beneficial interest Abstain: 596,799.177 Shares of beneficial interest 2i: Elimination of fundamental investment restrictions with respect to short sales. For: 14,718,294.140 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 972,030.158 Shares of beneficial interest Abstain: 591,159.554 Shares of beneficial interest 2k: Elimination of fundamental investment restrictions with respect to purchasing securities of companies less than three years old. For: 14,949,813.641 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 742,325.656 Shares of beneficial interest Abstain: 589,344.555 Shares of beneficial interest 2l: Fund investment restrictions for purchasing or holding securities of any company, if securities are owned by officers, directors, advisor. For: 14,778,938.207 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 904,549.378 Shares of beneficial interest Abstain: 597,996.267 Shares of beneficial interest 3. To approve the Reorganization of each Fund into a separate, corresponding series of Columbia Funds Trust. For: 15,021,875.104 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 645,753.099 Shares of beneficial interest Abstain: 613,855.649 Shares of beneficial interest On October 7, 2005, a Special Meeting of the Shareholders of the Fund was held to approve the following items, as described in the combined Proxy Statement/Prospectus for the Meeting. The votes cast at the meeting are as follows: To elect Trustees: For Withheld Abstain Douglas A. Hacker 20,624,204.201 792,659.095 145,420.329 Janet Langford Kelly 20,647,401.037 769,462.259 145,420.329 Richard W. Lowry 20,637,555.625 781,661.452 143,066.548 Charles R. Nelson 20,688,128.470 764,543.692 109,611.463 John J. Neuhauser 20,647,903.594 768,959.702 145,420.329 Patrick J. Simpson 20,650,734.818 766,128.478 145,420.329 Thomas E. Stitzel 20,642,778.754 774,084.542 145,420.359 Thomas C. Theobald 20,636,346.420 780,549.095 145,388.110 Anne-Lee Verville 20,647,985.419 769,942.986 144,355.220 Richard L. Woolworth 20,654,031.219 765,515.835 142,736.571 William E. Mayer 20,265,772.459 1,151,090.837 145,420.329 2a: Amendment to fundamental investment restrictions with respect to borrowing money, pledging assets, and issuing senior securities. For: 15,748,411.891 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 956,398.989 Shares of beneficial interest Abstain: 780,535.745 Shares of beneficial interest 2b: Amendment to fundamental investment restrictions with respect to making loans For: 15,783,967.100 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 910,865.340 Shares of beneficial interest Abstain: 790,514.185 Shares of beneficial interest 2c: Amendment to fundamental investment restrictions with respect to diversification of investments. For: 15,844,792.507 shares of beneficial interest being a majority of the shares represented at the meeting. Against: 844,708.056 shares of beneficial interest Abstain: 795,846.062 shares of beneficial interest 2d: Amendment to fundamental investment restrictions with respect to investments in commodities For: 15,789,219.711 shares of beneficial interest being a majority of the shares represented at the meeting. Against: 923,013.346 shares of beneficial interest Abstain: 773,113.568 shares of beneficial interest 2e: Amendment to fundamental investment restrictions with respect to investments in real estate. For: 15,990,673.410 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 685,724.821 Shares of beneficial interest Abstain: 808,948.394 Shares of beneficial interest 2f: Amendment to fundamental investment restrictions with respect to underwriting of securities. For: 15,809,015.927 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 857,575.420 Shares of beneficial interest Abstain: 818,755.278 Shares of beneficial interest 2g: Elimination of fundamental investment restrictions with respect to purchasing securities on margin For: 15,559,623.667 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 1,125,000.934 Shares of beneficial interest Abstain: 800,722.024 Shares of beneficial interest 2h: Elimination of fundamental inv restrictions with respect to investing for the purpose of exercising control. For: 15,719,973.647 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 956,558.896 Shares of beneficial interest Abstain: 808,814.082 Shares of beneficial interest 2i: Elimination of fundamental investment restrictions with respect to short sales. For: 15,644,197.727 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 1,040,301.764 Shares of beneficial interest Abstain: 800,847.134 Shares of beneficial interest 2k: Elimination of fundamental investment restrictions with respect to purchasing securities of companies less than three years old. For: 15,880,735.101 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 801,349.489 Shares of beneficial interest Abstain: 803,262.035 Shares of beneficial interest 2l: Fund investment restrictions for purchasing or holding securities of any company , if securities are owned by officers, directors, advisor. For: 15,657,289.098 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 1,020,746.957 Shares of beneficial interest Abstain: 807,310.570 Shares of beneficial interest 3. To approve the Reorganization of each Fund into a separate, corresponding series of Columbia Funds Trust. For: 15, 951,613.159 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 704,324.183 Shares of beneficial interest Abstain: 829,409.283 Shares of beneficial interest Columbia Oregon Intermediate Municipal Bond Fund 77C Matters submitted to a vote of security holders On September 16, 2005, a Special Meeting of the Shareholders of the Fund was held to approve the following items, as described in the combined Proxy Statement/Prospectus for the Meeting. The votes cast at the meeting are as follows: To elect Trustees: For Withheld Abstain Douglas A. Hacker 22,089,386.650 1,615,062.401 511,193.861 Janet Langford Kelly 22,274,880.985 1,429,568.066 511,193.861 Richard W. Lowry 22,233,298.010 1,471,151.041 511,193.861 Charles R. Nelson 22,232,534.474 1,475,623.136 507,485.302 John J. Neuhauser 22,208,530.450 1,495,918.601 511,193.861 Patrick J. Simpson 22,159,751.364 1,546,757.935 509,133.613 Thomas E. Stitzel 22,242,956.608 1,461,492.443 511,193.861 Thomas C. Theobald 22,201,631.267 1,505,144.694 508,866.951 Anne-Lee Verville 22,130,749.452 1,575,759.847 509,133.613 Richard L. Woolworth 22,225,629.824 1,478,819.227 511,193.861 William E. Mayer 21,598,942.966 2,106,125.425 510,574.521 2a: Amendment to fundamental investment restrictions with respect to borrowing money, pledging assets, and issuing senior securities. For: 17,977,284.655 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 2,991,235.454 Shares of beneficial interest Abstain: 1,580,153.803 Shares of beneficial interest 2b: Amendment to fundamental investment restrictions with respect to making loans For: 17,749,645.885 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 3,194,788.713 Shares of beneficial interest Abstain: 1,604,239.314 Shares of beneficial interest 2d: Amendment to fundamental inv restrictions with respect to investments in commodities For: 17,801,010,943 shares of beneficial interest being a majority of the shares represented at the meeting. Against: 3,113,372.791 shares of beneficial interest Abstain: 1,634,290.178 shares of beneficial interest 2e: Amendment to fundamental investment restrictions with respect to investments in real estate. For: 18,328,517.874 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 2,605,657.573 Shares of beneficial interest Abstain: 1,614,498.465 Shares of beneficial interest 2f: Amendment to fundamental investment restrictions with respect to underwriting of securities. For: 17,961,637.244 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 2,650,818.602 Shares of beneficial interest Abstain: 1,936,218.066 Shares of beneficial interest 2g: Elimination of fundamental investment restrictions with respect to purchasing securities on margin For: 17,489,062.395 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 3,323,483.741 Shares of beneficial interest Abstain: 1,736,127.776 Shares of beneficial interest 2h: Elimination of fundamental inv restrictions with respect to investing for the purpose of exercising control. For: 17,896,225.494 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 2,869,592.607 Shares of beneficial interest Abstain: 1,782,855.811 Shares of beneficial interest 2i: Elimination of fundamental investment restrictions with respect to short sales. For: 17,594,037.871 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 3,330,418.408 Shares of beneficial interest Abstain: 1,624,217.633 Shares of beneficial interest 2j: Amendment of fundamental investment restrictions with respect to concentrating investments in an industry. For: 18,008,367.600 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 2,897,990.883 Shares of beneficial interest Abstain: 1,642,315.429 Shares of beneficial interest 3. To approve the Reorganization of each Fund into a separate, corresponding series of Columbia Funds Trust. For: 17,891,376.293 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 2,754,176.156 Shares of beneficial interest Abstain: 1,903,121.463 Shares of beneficial interest Columbia Small Cap Growth Fund I 77C Matters submitted to a vote of security holders On September 16, 2005, a Special Meeting of the Shareholders of the Fund was held to approve the following items, as described in the combined Proxy Statement/Prospectus for the Meeting. The votes cast at the meeting were as follows: To elect Trustees: For Withheld Abstain Douglas A. Hacker 3,564,561.777 160,923.547 130,995.847 Janet Langford Kelly 3,569,076.893 155,957.181 131,447.097 Richard W. Lowry 3,570,130.553 155,105.067 131,245.551 Charles R. Nelson 3,570,782.188 154,251.886 131,447.097 John J. Neuhauser 3,567,499.522 157,715.005 131,266.644 Patrick J. Simpson 3,569,722.188 155,311.886 131,447.097 Thomas E. Stitzel 3,561,181.354 163,852.720 131,447.097 Thomas C. Theobald 3,561,582.998 163,451.076 131,447.097 Anne-Lee Verville 3,570,164.766 154,869.308 131,447.097 Richard L. Woolworth 3,571,423.790 153,610.284 131,447.097 William E. Mayer 3,198,809.793 526,224.281 131,447.097 2a: Amendment to fundamental investment restrictions with respect to borrowing money, pledging assets, and issuing senior securities. For: 2,845,483.175 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 243,062.880 Shares of beneficial interest Abstain: 262,489.116 Shares of beneficial interest 2b: Amendment to fundamental investment restrictions with respect to making loans For: 2,861,746.090 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 222,979.275 Shares of beneficial interest Abstain: 266,309.806 Shares of beneficial interest 2c: Amendment to fundamental investment restrictions with respect to diversification of investments. For: 2,878,613.857 shares of beneficial interest being a majority of the shares represented at the meeting. Against: 201,385.156 shares of beneficial interest Abstain: 271,036.158 shares of beneficial interest 2d: Amendment to fundamental inv restrictions with respect to investments in commodities For: 2,833,563.177 shares of beneficial interest being a majority of the shares represented at the meeting. Against: 254,979.403 shares of beneficial interest Abstain: 262,492.591 shares of beneficial interest 2e: Amendment to fundamental investment restrictions with respect to investments in real estate. For: 2,873,561.646 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 215,435.415 Shares of beneficial interest Abstain: 262,038.110 Shares of beneficial interest 2f: Amendment to fundamental investment restrictions with respect to underwriting of securities. For: 2,849,390.825 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 238,030.807 Shares of beneficial interest Abstain: 263,613.538 Shares of beneficial interest 2h: Elimination of fundamental inv restrictions with respect to investing for the purpose of exercising control. For: 2,887,055.162 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 188,932.374 Shares of beneficial interest Abstain: 275,047.635 Shares of beneficial interest 2i: Elimination of fundamental investment restrictions with respect to short sales. For: 2,824,038.193 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 256,501.777 Shares of beneficial interest Abstain: 270,495.201 Shares of beneficial interest 2j: Amendment of fundamental investment restrictions with respect to concentrating investments in an industry. For: 2,868,757.506 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 221,427.233 Shares of beneficial interest Abstain: 260,850.432 Shares of beneficial interest 2k: Elimination of fundamental investment restrictions with respect to purchasing securities of companies less than three years old. For: 2,893,037.406 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 195,359.335 Shares of beneficial interest Abstain: 262,638.430 Shares of beneficial interest 2m: Elimination of fundamental investment restrictions with respect to buying and selling puts and calls. For: 2,844,559.902 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 236,282.886 Shares of beneficial interest Abstain: 270,192.383 Shares of beneficial interest 3. To approve the Reorganization of each Fund into a separate, corresponding series of Columbia Funds Trust. For: 2,875,552.470 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 168,373.280 Shares of beneficial interest Abstain: 307,109.421 Shares of beneficial interest Columbia Strategic Investor Fund 77C Matters submitted to a vote of security holders On September 16, 2005, a Special Meeting of the Shareholders of the Fund was held to approve the following items, as described in the combined Proxy Statement/Prospectus for the Meeting. Item 3 was adjourned to November 16, 2005. Below are the votes cast at the September 16, 2005 meeting; To elect Trustees: For Withheld Abstain Douglas A. Hacker 16,429,708.467 511,161.579 178,093.883 Janet Langford Kelly 16,448,644.245 489,785.033 180,534.651 Richard W. Lowry 16,443,316.053 495,113.225 180,534.651 Charles R. Nelson 16,474,614.198 463,815.080 180,534.651 John J. Neuhauser 16,443,770.710 495,055.679 180,137.540 Patrick J. Simpson 16,448,521.499 490,048.372 180,394.058 Thomas E. Stitzel 16,408,388.922 530,040.356 180,534.651 Thomas C. Theobald 16,406,370.337 532,976.000 179,617.592 Anne-Lee Verville 16,445,312.189 494,352.083 179,299.657 Richard L. Woolworth 16,470,735.212 469,184.837 179,043.880 William E. Mayer 15,944,423.101 995,756.142 178,784.686 2a: Amendment to fundamental investment restrictions with respect to borrowing money, pledging assets, and issuing senior securities. For: 8, 697,972.602 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 718,168.990 Shares of beneficial interest Abstain: 650,278.337 Shares of beneficial interest 2b: Amendment to fundamental investment restrictions with respect to making loans For: 8,738,209.820 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 678,489.467 Shares of beneficial interest Abstain: 649,720.642 Shares of beneficial interest 2c: Amendment to fundamental investment restrictions with respect to diversification of investments. For: 8,846,877.872 shares of beneficial interest being a majority of the shares represented at the meeting. Against: 529,617.615 shares of beneficial interest Abstain: 689,924.442 shares of beneficial interest 2d: Amendment to fundamental investment restrictions with respect to investments in commodities For: 8,692,790.071 shares of beneficial interest being a majority of the shares represented at the meeting. Against: 709,975.202 shares of beneficial interest Abstain: 663,654.656 shares of beneficial interest 2e: Amendment to fundamental investment restrictions with respect to investments in real estate. For: 8,832,139.058 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 585,621.406 Shares of beneficial interest Abstain: 648,659.465 Shares of beneficial interest 2f: Amendment to fundamental investment restrictions with respect to underwriting of securities. For: 8,757,869.410 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 619,100.645 Shares of beneficial interest Abstain: 689,449.874 Shares of beneficial interest 2h: Elimination of fundamental inv restrictions with respect to investing for the purpose of exercising control. For: 8,678,006.608 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 729,399.244 Shares of beneficial interest Abstain: 659,014.077 Shares of beneficial interest 2i: Elimination of fundamental investment restrictions with respect to short sales. For: 8,552,779.044 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 839,803.634 Shares of beneficial interest Abstain: 673,837.251 Shares of beneficial interest 2j: Amendment of fundamental investment restrictions with respect to concentrating investments in an industry. For: 8,703,636.857 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 706,724.616 Shares of beneficial interest Abstain: 656,058.456 Shares of beneficial interest 2k: Elimination of fundamental investment restrictions with respect to purchasing securities of companies less than three years old. For: 8,812,182.374 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 593,368.487 Shares of beneficial interest Abstain: 660,869.068 Shares of beneficial interest 3. To approve the Reorganization of each Fund into a separate, corresponding series of Columbia Funds Trust. For: 8,796,370.025 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 563,030.888 Shares of beneficial interest Abstain: 707,019.016 Shares of beneficial interest 77C Matters submitted to a vote of security holders On November 16, 2005, a Special Meeting of the Shareholders of the Fund was held to approve the following item, as described in the combined Proxy Statement/Prospectus for the Meeting. The votes cast at the meeting are as follows: 3. To approve the Reorganization of each Fund into a separate, corresponding series of Columbia Funds Trust. For: 12,949,043.629 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 1,124,888.140 Shares of beneficial interest Abstain: 1,189,139.666 Shares of beneficial interest Columbia Technology Fund 77C Matters submitted to a vote of security holders On October 7, 2005, a Special Meeting of the Shareholders of the Fund was held to approve the following items, as described in the combined Proxy Statement/Prospectus for the Meeting. Item 3 was adjourned to November 16, 2005. Below are the votes cast at the October 7, 2005 meeting: To elect Trustees: To elect Trustees: For Withheld Abstain Douglas A. Hacker 3,267,039.650 246,988.580 92,881.036 Janet Langford Kelly 3,269,392.176 245,181.846 92,335.244 Richard W. Lowry 3,269,359.791 247,863.657 89,685.818 Charles R. Nelson 3,265,811.366 248,216.864 92,881.036 John J. Neuhauser 3,268,905.954 245,522.972 92,480.340 Patrick J. Simpson 3,269,165.384 244,862.846 92,881.036 Thomas E. Stitzel 3,266,364.908 247,663.322 92,881.036 Thomas C. Theobald 3,267,081.161 247,347.765 92,480.340 Anne-Lee Verville 3,269,247.080 245,181.846 92,480.340 Richard L. Woolworth 3,268,053.945 246,374.981 92,480.340 William E. Mayer 3,250,329.872 264,099.054 92,480.340 2a: Amendment to fundamental investment restrictions with respect to borrowing money, pledging assets, and issuing senior securities. For: 2,511,233.942 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 140,414.413 Shares of beneficial interest Abstain: 282,763.911 Shares of beneficial interest 2b: Amendment to fundamental investment restrictions with respect to making loans For: 2,503,567.180 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 145,338.337 Shares of beneficial interest Abstain: 285,506.749 Shares of beneficial interest 2d: Amendment to fundamental investment restrictions with respect to investments in commodities For: 1,497,664.595 shares of beneficial interest being a majority of the shares represented at the meeting. Against: 149,501.026 shares of beneficial interest Abstain: 287,246.645 shares of beneficial interest 2e: Amendment to fundamental investment restrictions with respect to investments in real estate. For: 2,528,039.010 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 144,666.080 Shares of beneficial interest Abstain: 261,707.176 Shares of beneficial interest 2f: Amendment to fundamental investment restrictions with respect to underwriting of securities. For: 2,504,474.110 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 145,372.437 Shares of beneficial interest Abstain: 284,565.719 Shares of beneficial interest 2g: Elimination of fundamental investment restrictions with respect to purchasing securities on margin For: 2,490,115.088 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 163,475.567 Shares of beneficial interest Abstain: 280,821.611 Shares of beneficial interest 2h: Elimination of fundamental inv restrictions with respect to investing for the purpose of exercising control. For: 2,501,242.004 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 143,260.039 Shares of beneficial interest Abstain: 289,910.223 Shares of beneficial interest 2i: Elimination of fundamental investment restrictions with respect to short sales. For: 2,496,006.559 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 156,058.454 Shares of beneficial interest Abstain: 282,347.253 Shares of beneficial interest 2j: Amendment of fundamental investment restrictions with respect to concentrating investments in an industry. For: 2,508,527.035 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 143,506.485 Shares of beneficial interest Abstain: 282,378.746 Shares of beneficial interest 2k: Elimination of fundamental investment restrictions with respect to purchasing securities of companies less than three years old. For: 2,518,824.368 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 142,125.103 Shares of beneficial interest Abstain: 273,462.794 Shares of beneficial interest 3. To approve the Reorganization of each Fund into a separate, corresponding series of Columbia Funds Trust. For: 2,507,575.174 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 140,872.123 Shares of beneficial interest Abstain: 285,964.969 Shares of beneficial interest On November 16, 2005, a Special Meeting of the Shareholders of the Fund was held to approve the following items, as described in the combined Proxy Statement/Prospectus for the Meeting. The votes cast at the meeting are as follows: To approve the Reorganization of each Fund into a separate, corresponding series of Columbia Funds Trust. For: 3,343,238.011 Shares of beneficial interest being a majority of the shares represented at the meeting. Against: 158,059.959 Shares of beneficial interest Abstain: 887,410.880 Shares of beneficial interest 77D Policies with respect to security investments Columbia Greater China Fund Effective January 1, 2006, the following language replaced the language in the section of the Statement of Additional Information entitled "FUNDAMENTAL INVESTMENT POLICIES: FUNDAMENTAL INVESTMENT POLICIES The Fund may not, as a matter of fundamental policy: 1. Underwrite any issue of securities issued by other persons within the meaning of the Securities Act of 1933, as amended (the "1933 Act") except when it might be deemed to be an underwriter either: (a) in connection with the disposition of a portfolio security; or (b) in connection with the purchase of securities directly from the issuer thereof in accordance with its investment objective. This restriction shall not limit the Fund's ability to invest in securities issued by other registered investment companies. 2. Purchase or sell real estate, except the Fund may purchase securities of issuers which deal or invest in real estate and may purchase securities which are secured by real estate or interests in real estate and it may hold and dispose of real estate or interests in real estate acquired through the exercise of its rights as a holder of securities which are secured by real estate or interests therein. 3. Purchase or sell commodities, except that the Fund may to the extent consistent with its investment objective, invest in securities of companies that purchase or sell commodities or which invest in such programs, and purchase and sell options, forward contracts, futures contracts, and options on futures contracts and enter into swap contracts and other financial transactions relating to commodities. This limitation does not apply to foreign currency transactions including without limitation forward currency contracts. 4. Purchase any securities which would cause 25% or more of the value of its total assets at the time of purchase to be invested in the securities of one or more issuers conducting their principal business activities in the same industry, provided that: (a) there is no limitation with respect to obligations issued or guaranteed by the U.S. Government, any state or territory of the United States, or any of their agencies, instrumentalities or political subdivisions; and (b) notwithstanding this limitation or any other fundamental investment limitation, assets may be invested in the securities of one or more management investment companies to the extent permitted by the 1940 Act, the rules and regulations thereunder and any applicable exemptive relief. 5. Make loans, except to the extent permitted by the 1940 Act, the rules and regulations thereunder and any applicable exemptive relief. 6. Borrow money or issue senior securities except to the extent permitted by the 1940 Act, the rules and regulations thereunder and any applicable exemptive relief. 7. Purchase securities (except securities issued or guaranteed by the U.S. Government, its agencies or instrumentalities) of any one issuer if, as a result, more than 5% of its total assets will be invested in the securities of such issuer or it would own more than 10% of the voting securities of such issuer, except that: (a) up to 50% of its total assets may be invested without regard to these limitations and (b) a Fund's assets may be invested in the securities of one or more management investment companies to the extent permitted by the 1940 Act, the rules and regulations thereunder, or any applicable exemptive relief. 77D Policies with respect to security investments cont'd Columbia Balanced Fund Columbia Conservative High Yield Fund (formerly Columbia High Yield Fund, Inc.) Columbia Real Estate Equity Fund Columbia Oregon Intermediate Municipal Bond Fund Columbia Small Cap Growth Fund I Columbia Strategic Investor Fund Columbia Technology Fund Effective November 1, 2005, the following language replaced the language in the section of the Statement of Additional Information entitled "FUNDAMENTAL INVESTMENT POLICIES: FUNDAMENTAL INVESTMENT POLICIES The Investment Company Act of 1940, as amended (1940 Act), provides that a "vote of a majority of the outstanding voting securities" means the affirmative vote of the lesser of (1) more than 50% of the outstanding shares of a Fund, or (2) 67% or more of the shares present at a meeting if more than 50% of the outstanding shares are represented at the meeting in person or by proxy. The following fundamental investment policies cannot be changed without such a vote. The Fund may not, as a matter of fundamental policy: 1. Underwrite any issue of securities issued by other persons within the meaning of the 1933 Act except when it might be deemed to be an underwriter either: (a) in connection with the disposition of a portfolio security; or (b) in connection with the purchase of securities directly from the issuer thereof in accordance with its investment objective. This restriction shall not limit the Portfolio's ability to invest in securities issued by other registered investment companies. 2. Purchase or sell real estate, except a Fund may purchase securities of issuers which deal or invest in real estate and may purchase securities which are secured by real estate or interests in real estate and it may hold and dispose of real estate or interests in real estate acquired through the exercise of its rights as a holder of securities which are secured by real estate or interests therein. 3. Purchase or sell commodities, except that a Fund may to the extent consistent with its investment objective, invest in securities of companies that purchase or sell commodities or which invest in such programs, and purchase and sell options, forward contracts, futures contracts, and options on futures contracts and enter into swap contracts and other financial transactions relating to commodities. This limitation does not apply to foreign currency transactions including without limitation forward currency contracts. 4. With the exception of the Real Estate Fund, which will invest at least 65% of the value of its total assets in securities of companies principally engaged in the real estate industry, purchase any securities which would cause 25% or more of the value of its total assets at the time of purchase to be invested in the securities of one or more issuers conducting their principal business activities in the same industry, provided that: (a) there is no limitation with respect to obligations issued or guaranteed by the U.S. Government, any state or territory of the United States, or any of their agencies, instrumentalities or political subdivisions; and (b) notwithstanding this limitation or any other fundamental investment limitation, assets may be invested in the securities of one or more management investment companies to the extent permitted by the 1940 Act, the rules and regulations thereunder and any applicable exemptive relief. 5. Make loans, except to the extent permitted by the 1940 Act, the rules and regulations thereunder and any applicable exemptive relief. 6. Borrow money or issue senior securities except to the extent permitted by the 1940 Act, the rules and regulations thereunder and any applicable exemptive relief. 7. With the exception of the Oregon Intermediate Municipal Bond Fund and Technology Fund, purchase securities (except securities issued or guaranteed by the U.S. Government, its agencies or instrumentalities) of any one issuer if, as a result, more than 5% of its total assets will be invested in the securities of such issuer or it would own more than 10% of the voting securities of such issuer, except that: (a) up to 25% of its total assets may be invested without regard to these limitations and (b) a Fund's assets may be invested in the securities of one or more management investment companies to the extent permitted by the 1940 Act, the rules and regulations thereunder, or any applicable exemptive relief. Columbia Federal Securities Fund Columbia International Stock Fund 77D Policies with repect to security investments On November 1, 2005, the following language replaced the language currently in the section of the Statement of Additional Information entitled FUNDAMENTAL INVESTMENT POLICIES: FUNDAMENTAL INVESTMENT POLICIES The Investment Company Act of 1940, as amended (1940 Act), provides that a "vote of a majority of the outstanding voting securities" means the affirmative vote of the lesser of (1) more than 50% of the outstanding shares of a Fund, or (2) 67% or more of the shares present at a meeting if more than 50% of the outstanding shares are represented at the meeting in person or by proxy. The following fundamental investment policies cannot be changed without such a vote. The Fund may not, as a matter of fundamental policy: 1. Underwrite any issue of securities issued by other persons within the meaning of the 1933 Act except when it might be deemed to be an underwriter either: (a) in connection with the disposition of a portfolio security; or (b) in connection with the purchase of securities directly from the issuer thereof in accordance with its investment objective. This restriction shall not limit the Fund's ability to invest in securities issued by other registered investment companies. 2. Purchase or sell real estate, except a Fund may purchase securities of issuers which deal or invest in real estate and may purchase securities which are secured by real estate or interests in real estate and it may hold and dispose of real estate or interests in real estate acquired through the exercise of its rights as a holder of securities which are secured by real estate or interests therein. 3. Purchase or sell commodities, except that a Fund may to the extent consistent with its investment objective, invest in securities of companies that purchase or sell commodities or which invest in such programs, and purchase and sell options, forward contracts, futures contracts, and options on futures contracts and enter into swap contracts and other financial transactions relating to commodities. This limitation does not apply to foreign currency transactions including without limitation forward currency contracts. 4. Purchase any securities which would cause 25% or more of the value of its total assets at the time of purchase to be invested in the securities of one or more issuers conducting their principal business activities in the same industry, provided that: (a) there is no limitation with respect to obligations issued or guaranteed by the U.S. Government, any state or territory of the United States, or any of their agencies, instrumentalities or political subdivisions; and (b) notwithstanding this limitation or any other fundamental investment limitation, assets may be invested in the securities of one or more management investment companies to the extent permitted by the 1940 Act, the rules and regulations thereunder and any applicable exemptive relief. 5. Make loans, except to the extent permitted by the 1940 Act, the rules and regulations thereunder and any applicable exemptive relief. 6. Borrow money or issue senior securities except to the extent permitted by the 1940 Act, the rules and regulations thereunder and any applicable exemptive relief. 7. Purchase securities (except securities issued or guaranteed by the U.S. Government, its agencies or instrumentalities) of any one issuer if, as a result, more than 5% of its total assets will be invested in the securities of such issuer or it would own more than 10% of the voting securities of such issuer, except that: (a) up to 25% of its total assets may be invested without regard to these limitations and (b) a Fund's assets may be invested in the securities of one or more management investment companies to the extent permitted by the 1940 Act, the rules and regulations thereunder, or any applicable exemptive relief. COLUMBIA MID CAP GROWTH FUND (THE "FUND") 77D Policies with respect to security investments On February 17, 2006, The third paragraph under the heading "THE FUND; PRINCIPAL INVESTMENT STRATEGIES" is revised in its entirety as follows (Class R share prospectus only): The Fund may also invest in securities convertible into or exercisable for stock (including preferred stock, warrants and debentures), and certain options and financial futures contracts (derivatives). The Fund may also invest, to a limited extent, in foreign securities, including American Depository Receipts. The Fund may invest up to 20% of its total assets in foreign securities. 77D Policies with respect to security investments Effective November 1, 2005, the following language replaced the language in the section of the Statement of Additional Information entitled "FUNDAMENTAL INVESTMENT POLICIES: FUNDAMENTAL INVESTMENT POLICIES The Investment Company Act of 1940, as amended (1940 Act), provides that a "vote of a majority of the outstanding voting securities" means the affirmative vote of the lesser of (1) more than 50% of the outstanding shares of a Fund, or (2) 67% or more of the shares present at a meeting if more than 50% of the outstanding shares are represented at the meeting in person or by proxy. The following fundamental investment policies cannot be changed without such a vote. The Fund may not, as a matter of fundamental policy: 1. Underwrite any issue of securities issued by other persons within the meaning of the 1933 Act except when it might be deemed to be an underwriter either: (a) in connection with the disposition of a portfolio security; or (b) in connection with the purchase of securities directly from the issuer thereof in accordance with its investment objective. This restriction shall not limit the Portfolio's ability to invest in securities issued by other registered investment companies. 2. Purchase or sell real estate, except a Fund may purchase securities of issuers which deal or invest in real estate and may purchase securities which are secured by real estate or interests in real estate and it may hold and dispose of real estate or interests in real estate acquired through the exercise of its rights as a holder of securities which are secured by real estate or interests therein. 3. Purchase or sell commodities, except that a Fund may to the extent consistent with its investment objective, invest in securities of companies that purchase or sell commodities or which invest in such programs, and purchase and sell options, forward contracts, futures contracts, and options on futures contracts and enter into swap contracts and other financial transactions relating to commodities. This limitation does not apply to foreign currency transactions including without limitation forward currency contracts. 4. Purchase any securities which would cause 25% or more of the value of its total assets at the time of purchase to be invested in the securities of one or more issuers conducting their principal business activities in the same industry, provided that: (a) there is no limitation with respect to obligations issued or guaranteed by the U.S. Government, any state or territory of the United States, or any of their agencies, instrumentalities or political subdivisions; and (b) notwithstanding this limitation or any other fundamental investment limitation, assets may be invested in the securities of one or more management investment companies to the extent permitted by the 1940 Act, the rules and regulations thereunder and any applicable exemptive relief. 5. Make loans, except to the extent permitted by the 1940 Act, the rules and regulations thereunder and any applicable exemptive relief. 6. Borrow money or issue senior securities except to the extent permitted by the 1940 Act, the rules and regulations thereunder and any applicable exemptive relief. 7. Purchase securities (except securities issued or guaranteed by the U.S. Government, its agencies or instrumentalities) of any one issuer if, as a result, more than 5% of its total assets will be invested in the securities of such issuer or it would own more than 10% of the voting securities of such issuer, except that: (a) up to 25% of its total assets may be invested without regard to these limitations and (b) a Fund's assets may be invested in the securities of one or more management investment companies to the extent permitted by the 1940 Act, the rules and regulations thereunder, or any applicable exemptive relief. Columbia Mid Cap Growth Fund cont'd 77D Policies with respect to security investments cont'd On February 17, 2006, the non-fundamental investment restrictions section for the Fund was revised in its entirety as follows (CLass R prospectus only): The following is a list of non-fundamental investment restrictions applicable to the Fund. These restrictions can be changed by the Board, but the change will only be effective after notice is given (60 days notice in the case of non- fundamental restriction #2) to shareholders of the Fund. The Fund may not: 1. Purchase or otherwise acquire any security if, as a result, more than 15% of its net assets would be invested in securities that are illiquid. 2. Invest less than 80% of its assets in the stocks of mid-cap companies (those stocks with a market capitalization, at the time of initial purchase, equal to or less than the largest stock in the Russell Mid Cap Index), except when the Fund is taking a temporary defensive position due to a determination by the Fund's Advisor that adverse market conditions make it desirable to suspend temporarily the Fund's normal investment activities. 3. Invest more than 20% of its total assets in foreign securities. Columbia Mid Cap Growth Fund 77I Terms of new or amended securities Effective January 17, 2006 Class R shares were offered by Columbia MidCap Growth Fund (Fund). Such shares are offered at net asset value without any initial or contingent deferred sales charges or Rule 12b-1 fees. 77E Legal Proceedings Columbia Federal Securities Fund Columbia International Stock Fund Columbia Balanced Fund Columbia Greater China Fund Columbia Conservative High Yield Fund Columbia Mid Cap Growth Fund Columbia Oregon Intermediate Municipal Bond Fund Columbia Real Estate Equity Fund Columbia Small Cap Growth Fund I Columbia Strategic Investor Fund Columbia Technology Fund (Funds) On February 9, 2005, Columbia Management Advisors, Inc. (which has since merged into Banc of America Capital Management, LLC (now named Columbia Management Advisors, LLC)) ("Columbia") and Columbia Funds Distributor, Inc. (which has been renamed Columbia Management Distributors, Inc.) (the "Distributor") (collectively, the "Columbia Group") entered into an Assurance of Discontinuance with the New York Attorney General ("NYAG") (the "NYAG Settlement") and consented to the entry of a cease-and-desist order by the Securities and Exchange Commission ("SEC") (the "SEC Order"). The SEC Order and the NYAG Settlement are referred to collectively as the "Settlements". The Settlements contain substantially the same terms and conditions as outlined in the agreements in principle which Columbia Group entered into with the SEC and NYAG in March, 2004. Under the terms of the SEC Order, the Columbia Group has agreed among other things, to: pay $70 million in disgorgement and $70 million in civil money penalties; cease and desist from violations of the antifraud provisions and certain other provisions of the federal securities laws; maintain certain compliance and ethics oversight structures; retain an independent consultant to review the Columbia Group's applicable supervisory, compliance, control and other policies and procedures; and retain an independent distribution consultant (see below). The Columbia Funds have also voluntarily undertaken to implement certain governance measures designed to maintain the independence of their boards of trustees. The NYAG Settlement also, among other things, requires Columbia and its affiliates to reduce certain Columbia Funds (including the former Nations Funds) and other mutual funds management fees collectively by $32 million per year for five years, for a projected total of $160 million in management fee reductions. Pursuant to the procedures set forth in the SEC order, the $140 million in settlement amounts described above will be distributed in accordance with a distribution plan developed by an independent distribution consultant and agreed to by the staff of the SEC. The independent distribution consultant has been in consultation with the Staff, and has submitted a draft proposed plan of distribution, but has not yet submitted a final proposed plan of distribution. As a result of these matters or any adverse publicity or other developments resulting from them, there may be increased redemptions or reduced sales of fund shares, which could increase transaction costs or operating expenses, or have other adverse consequences for the funds. A copy of the SEC Order is available on the SEC website at http://www.sec.gov. A copy of the NYAG Settlement is available as part of the Bank of America Corporation Form 8-K filing on February 10, 2005. In connection with the events described in detail above, various parties have filed suit against certain funds, the Trustees of the Columbia Funds, FleetBoston Financial Corporation and its affiliated entities and/or Bank of America and its affiliated entities. On February 20, 2004, the Judicial Panel on Multidistrict Litigation transferred these cases and cases against several other mutual fund companies based on similar allegations to the United States District Court in Maryland for consolidated or coordinated pretrial proceedings (the "MDL"). Subsequently, additional related cases were transferred to the MDL. On September 29, 2004, the plaintiffs in the MDL filed amended and consolidated complaints. One of these amended complaints is a putative class action that includes claims under the federal securities laws and state common law, and that names Columbia, the Distributor, the Trustees of the Columbia Funds, Bank of America Corporation and others as defendants. Another of the amended complaints is a derivative action purportedly on behalf of the Columbia Funds that asserts claims under federal securities laws and state common law. On February 25, 2005, Columbia and other defendants filed motions to dismiss the claims in the pending cases. On March 1, 2006, for reasons stated in the court's memoranda dated November 3, 2005, the U.S. District Court for the District of Maryland granted in part and denied in part the defendants' motions to dismiss. The court dismissed all of the class action claims pending against the Columbia Funds. As to Columbia, the Distributor and the Trustees of the Columbia Funds, the claims under the Securities Act of 1933, the claims under Sections 34(b) and 36(a) of the Investment Company Act of 1940 (ICA) and the state law claims were dismissed. The claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and claims under Section 36(b) of the ICA along with related claims under Section 48(a) of the ICA were not dismissed. On March 21, 2005 purported class action plaintiffs filed suit in Massachusetts state court alleging that the conduct, including market timing, entitles Class B shareholders in certain Columbia funds to an exemption from contingent deferred sales charges upon early redemption ("the CDSC Lawsuit"). The CDSC Lawsuit has been removed to federal court in Massachusetts and the federal Judicial Panel has transferred the CDSC Lawsuit to the MDL. The MDL is ongoing. Accordingly, an estimate of the financial impact of this litigation on any fund, if any, cannot currently be made. In 2004, certain Columbia funds, the Trustees of the Columbia Funds, advisers and affiliated entities were named as defendants in certain purported shareholder class and derivative actions making claims, including claims under the Investment Company and the Investment Advisers Acts of 1940 and state law. The suits allege, inter alia, that the fees and expenses paid by the funds are excessive and that the advisers and their affiliates inappropriately used fund assets to distribute the funds and for other improper purpose. On March 2, 2005, the actions were consolidated in the Massachusetts federal court as In re Columbia Entities Litigation. The plaintiffs filed a consolidated amended complaint on June 9, 2005. On November 30, 2005, the judge dismissed all claims by plaintiffs and ordered that the case be closed. The plaintiffs filed a notice of appeal on December 30, 2005 and this appeal is pending. 77M Mergers Columbia International Stock Fund On September 16, 2005, the shareholders of Columbia Newport Tiger Fund (Fund) approved an Agreement and Plan of Reorganization providing for (i) the sale of all of the assets of Columbia Newport Tiger Fund to, and the assumption of all of the liabilities of, Columbia Newport Tiger Fund by, Columbia International Stock Fund, in exchange for shares of Columbia International Stock Fund, and (ii) the distribution of such shares to the shareholders of Columbia Newport Tiger Fund in complete liquidation of Columbia Newport Tiger Fund. Following the reorganization, Columbia International STock Fund, was reorganized as a newly- formed series of Columbia Funds Series Trust I. Columbia Federal Securties Fund Columbia International Stock Fund (Funds) 77M Mergers On September 19, 2005, the Board of Trustees approved the reorganization of the Funds as a newly-formed series of Columbia Funds Series Trust I. The primary purpose of the Trust Reorganization is to facilitate compliance monitoring and administration for the Columbia Funds. Columbia Balanced Fund Columbia Conservative High Yield Fund Columbia Oregon Intermediate Municipal Bond Fund Columbia Real Estate Equity Fund Columbia Small Cap Growth Fund I Columbia Mid Cap Growth Fund Columbia Strategic Investor Fund Columbia Technology Fund (Funds) 77M Mergers On March 27, 2006, the Board of Trustees approved the reorganization of the Funds as a newly-formed series of Columbia Funds Series Trust I. The primary purpose of the Trust Reorganization is to facilitate compliance monitoring and administration for the Columbia Funds. 77O Transactions effected pursuant to Rule 10f-3 Columbia Conservative High Yield Fund On July 27, 2005, Columbia Conservative High Yield Fund (Fund) purchased 10,015,000 par value of notes of L-3 Communications (Securities) for a total purchase price of $9,923,863.50 from Lehman Brothers pursuant to a public offering in which Banc of America Securities acted as a participating underwriter. Banc of America Securities may be considered to be an affiliate of the Fund. The following information was collected pursuant to Rule 10f-3 procedures adopted by the Fund's Trustees: o The Fund's advisor, Columbia Management Advisors, Inc. (Advisor) o believed that the gross underwriting spread associated with the purchase of the Securities was reasonable and fair compared to the spreads in connection with similar underwritings of similar securities being sold during a comparable period of time; o The Securities were offered pursuant to an underwriting or similar agreement under which the underwriters were committed to purchase all of the Securities being offered; o The issuer of the Securities has been in continuous operation for at least three years; o The amount of Securities purchased did not exceed 25% of the amount of the offering; o The Securities were to be purchased at not more than the public offering price no later than the first day of the offering. Along with Banc of America Securities, the following is a list of members of the underwriting syndicate for the aforementioned Securities: Lehman Brothers; Bear Stearns & Co. Inc.; Credit Suisse First Boston Corp; BNY Capital Markets; Calyon Securities USA, Inc.; Morgan Stanley; Scotia Capital Inc.; SG Corporate & Investment Banking; Stephens, Inc.; Wachovia Securities, Inc. Columbia Conservative High Yield Fund On July 27, 2005, Columbia Conservative High Yield Fund (Fund) purchased 1,475,000 par value of notes of Sungard Data Systems Inc 9.125% '13 (Securities) for a total purchase price of $1,475,000 from Deutsche Bank pursuant to a public offering in which Banc of America Securities acted as a participating underwriter. Banc of America Securities may be considered to be an affiliate of the Fund. The following information was collected pursuant to Rule 10f-3 procedures adopted by the Fund's Trustees: o The Fund's advisor, Columbia Management Advisors, Inc. (Advisor) o believed that the gross underwriting spread associated with the purchase of the Securities was reasonable and fair compared to the spreads in connection with similar underwritings of similar securities being sold during a comparable period of time; o The Securities were offered pursuant to an underwriting or similar agreement under which the underwriters were committed to purchase all of the Securities being offered; o The issuer of the Securities has been in continuous operation for at least three years; o The amount of Securities purchased did not exceed 25% of the amount of the offering; o The Securities were to be purchased at not more than the public offering price no later than the first day of the offering. Along with Banc of America Securities, the following is a list of members of the underwriting syndicate for the aforementioned Securities: Deutsche Bank Securities; Citigroup; JPMorgan; Goldman, Sachs & Co.; Morgan Stanley; RBC Capital Markets; BNY Capital Markets, Inc. Columbia Conservative High Yield Fund On July 28, 2005, Columbia Conservative High Yield Fund (Fund) purchased 1,400,000 par value of notes of FTI Consulting 7.625% '13 (Securities) for a total purchase price of $1,400,000 from Goldman Sachs pursuant to a public offering in which Banc of America Securities acted as a participating underwriter. Banc of America Securities may be considered to be an affiliate of the Fund. The following information was collected pursuant to Rule 10f-3 procedures adopted by the Fund's Trustees: o The Fund's advisor, Columbia Management Advisors, Inc. (Advisor) o believed that the gross underwriting spread associated with the purchase of the Securities was reasonable and fair compared to the spreads in connection with similar underwritings of similar securities being sold during a comparable period of time; o The Securities were offered pursuant to an underwriting or similar agreement under which the underwriters were committed to purchase all of the Securities being offered; o The issuer of the Securities has been in continuous operation for at least three years; o The amount of Securities purchased did not exceed 25% of the amount of the offering; o The Securities were to be purchased at not more than the public offering price no later than the first day of the offering. Along with Banc of America Securities, the following is a list of members of the underwriting syndicate for the aforementioned Securities: Goldman, Sachs & Co. Columbia Conservative High Yield Fund On September 8, 2005, Columbia Conservative High Yield Fund (Fund) purchased 5,100,000 par value of notes of Amerisource Bergen Corp 5.62% 12 (Securities) for a total purchase price of $5,074,500 from Lehman Brothers pursuant to a public offering in which Banc of America Securities acted as a participating underwriter. Banc of America Securities may be considered to be an affiliate of the Fund. The following information was collected pursuant to Rule 10f-3 procedures adopted by the Fund's Trustees: o The Fund's advisor, Columbia Management Advisors, Inc. (Advisor) o believed that the gross underwriting spread associated with the purchase of the Securities was reasonable and fair compared to the spreads in connection with similar underwritings of similar securities being sold during a comparable period of time; o The Securities were offered pursuant to an underwriting or similar agreement under which the underwriters were committed to purchase all of the Securities being offered; o The issuer of the Securities has been in continuous operation for at least three years; o The amount of Securities purchased did not exceed 25% of the amount of the offering; o The Securities were to be purchased at not more than the public offering price no later than the first day of the offering. Along with Banc of America Securities, the following is a list of members of the underwriting syndicate for the aforementioned Securities: JPMorgan Securities; Lehman Brothers Columbia Small Cap Growth Fund I 77O Transactions effected pursuant to Rule 10f-3 On September 22, 2005, Columbia Small Cap Growth Fund I (Fund) purchased 118,005 par value of notes of Global Cash Access Holdings, Inc. (Securities) for a total purchase price of $1,652,070.00 from Goldman Sachs pursuant to a public offering in which Banc of America Securities acted as a participating underwriter. Banc of America Securities may be considered to be an affiliate of the Fund. The following information was collected pursuant to Rule 10f-3 procedures adopted by the Fund's Trustees: o The Fund's advisor, Columbia Management Advisors, Inc. (Advisor) o believed that the gross underwriting spread associated with the purchase of the Securities was reasonable and fair compared to the spreads in connection with similar underwritings of similar securities being sold during a comparable period of time; o The Securities were offered pursuant to an underwriting or similar agreement under which the underwriters were committed to purchase all of the Securities being offered; o The issuer of the Securities has been in continuous operation for at least three years; o The amount of Securities purchased did not exceed 25% of the amount of the offering; o The Securities were to be purchased at not more than the public offering price no later than the first day of the offering. Along with Banc of America Securities, the following is a list of members of the underwriting syndicate for the aforementioned Securities:Goldman Sachs & Co; JP Morgan Securities; Bear Stearns & Co. Inc; Citigroup; Deutsche Bank Securities Inc.; SG Cowen Securities Corp.; Wachovia Securities, Inc. Columbia Technology Fund 77O Transactions effected pursuant to Rule 10f-3 On July 21, 2005, Columbia Technology Fund (Fund) purchased 48,300 par value of notes of Consolidated Communications (Securities) for a total purchase price of $627,900 from CS First Boston/Citigroup pursuant to a public offering in which Banc of America Securities acted as a participating underwriter. Banc of America Securities may be considered to be an affiliate of the Fund. The following information was collected pursuant to Rule 10f-3 procedures adopted by the Fund's Trustees: o The Fund's advisor, Columbia Management Advisors, Inc. (Advisor) o believed that the gross underwriting spread associated with the purchase of the Securities was reasonable and fair compared to the spreads in connection with similar underwritings of similar securities being sold during a comparable period of time; o The Securities were offered pursuant to an underwriting or similar agreement under which the underwriters were committed to purchase all of the Securities being offered; o The issuer of the Securities has been in continuous operation for at least three years; o The amount of Securities purchased did not exceed 25% of the amount of the offering; o The Securities were to be purchased at not more than the public offering price no later than the first day of the offering. Along with Banc of America Securities, the following is a list of members of the underwriting syndicate for the aforementioned Securities: Credit Suisse First Boston; Citigroup; Deutsche Bank Securities; Lehman Brothers; Wachovia Securities 77Q1 Exhibits Management Agreement incorporated herein by reference to Accession Number 0000950135-05-005435